\-\ Texto\\:\\ \ \(0\)\
\-\ decrease\\ level\\ of\\ consciousness\ \(0\)\
\-\ \\â\\€\\¢\\ antihypertensive\\ therapy\ \(0\)\
\-\ \\â\\€\\¢\\ intubation\\ and\\ supportive\\ measures\ \(0\)\
\-\ \\â\\€\\¢\\ ct\\-\\-\\ high\\ attenuation\\ lesion\\ in\\ the\\ central\\ pons\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mri\\-\\-pontine\\ lesion\\ with\\ minimal\\ signal\\ intensity\\ change\\ on\\ t1\\ and\\ t2\\ scans\\.\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ contrast\\ enhancement\\.\ \(0\)\
\-\ pontine\\ hypertensive\\ hemorrhage\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ avm\ \(0\)\
\-\ \\â\\€\\¢\\ vasculitis\ \(1\)\
\-\ \\â\\€\\¢\\ hypertensive\\ vascular\\ disease\ \(0\)\
\-\ 53\\ year\\ old\\ woman\\ with\\ history\\ of\\ uncontrolled\\ hypertension\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.20739895829945576\ \(0\)\
\-\ pontine\\:\\ 0\\.1711701808944855\ \(0\)\
\-\ hypertensive\\:\\ 0\\.14865642083155692\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.11544615575719837\ \(0\)\
\-\ antihypertensive\\:\\ 0\\.10597177222841761\ \(0\)\
\-\ uncontrolled\\:\\ 0\\.09083031021104764\ \(0\)\
\-\ intubation\\:\\ 0\\.08012092049970623\ \(0\)\
\-\ pons\\:\\ 0\\.0718190116359143\ \(0\)\
\-\ 53\\:\\ 0\\.06780626183199312\ \(0\)\
\-\ vasculitis\\:\\ 0\\.06430687010994385\ \(0\)\
\-\ consciousness\\:\\ 0\\.06379678837482781\ \(0\)\
\-\ avm\\:\\ 0\\.059861563170636\ \(0\)\
\-\ scans\\:\\ 0\\.0585181840737503\ \(0\)\
\-\ decrease\\:\\ 0\\.0575035830224716\ \(0\)\
\-\ supportive\\:\\ 0\\.05556714443460102\ \(0\)\
\-\ measures\\:\\ 0\\.05377151654047013\ \(0\)\
\-\ lesion\\:\\ 0\\.05119280076471926\ \(0\)\
\-\ attenuation\\:\\ 0\\.050523839270971156\ \(0\)\
\-\ hypertension\\:\\ 0\\.04954089782794394\ \(0\)\
\-\ minimal\\:\\ 0\\.04947764662354114\ \(0\)\
\-\ change\\:\\ 0\\.04898119838935063\ \(0\)\
\-\ intensity\\:\\ 0\\.04542162759381325\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.04182730270847111\ \(0\)\
\-\ central\\:\\ 0\\.04134751995382293\ \(0\)\
\-\ vascular\\:\\ 0\\.04120298923417201\ \(0\)\
\-\ disease\\:\\ 0\\.04108051591810895\ \(0\)\
\-\ t1\\:\\ 0\\.03983081670918005\ \(0\)\
\-\ level\\:\\ 0\\.03621895628892547\ \(0\)\
\-\ t2\\:\\ 0\\.03556748189338753\ \(0\)\
\-\ high\\:\\ 0\\.03439038325112964\ \(0\)\
\-\ enhancement\\:\\ 0\\.03368365832533876\ \(0\)\
\-\ therapy\\:\\ 0\\.03359765876824431\ \(0\)\
\-\ signal\\:\\ 0\\.03313344603342321\ \(0\)\
\-\ metastatic\\:\\ 0\\.03163396181788368\ \(0\)\
\-\ woman\\:\\ 0\\.02902798452189568\ \(0\)\
\-\ mri\\:\\ 0\\.02887170374874441\ \(0\)\
\-\ contrast\\:\\ 0\\.028129054217763315\ \(0\)\
\-\ ct\\:\\ 0\\.01757799490282416\ \(0\)\
\-\ history\\:\\ 0\\.017356096142751225\ \(0\)\
\-\ year\\:\\ 0\\.014060371606954628\ \(0\)\
\-\ old\\:\\ 0\\.012866685247974333\ \(0\)\
\-\ no\\:\\ 0\\.0126535904515265\ \(0\)\
\-\ on\\:\\ 0\\.010645456064197471\ \(0\)\
\-\ in\\:\\ 0\\.006197018090297867\ \(0\)\
\-\ and\\:\\ 0\\.0052943825215358365\ \(0\)\
\-\ with\\:\\ 0\\.0034412992967614627\ \(0\)\
\-\ of\\:\\ 0\\.0034265823764114242\ \(0\)\
\-\ \\.\\:\\ 0\\.0020882080057262513\ \(0\)\
\-\ the\\:\\ 0\\.002033077716229791\ \(0\)\
